LEADER 04570nam 2201285z- 450 001 9910557437003321 005 20210501 035 $a(CKB)5400000000043353 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69362 035 $a(oapen)doab69362 035 $a(EXLCZ)995400000000043353 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRadiopharmaceuticals for PET Imaging - Issue A 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (212 p.) 311 08$a3-03943-242-7 311 08$a3-03943-243-5 330 $aPositron emission tomography (PET) is a very useful technique for medical diagnosis and drug development. Radiopharmaceuticals are a key element in PET techniques and one of the pivotal factors influencing the applications of PET. The aim of this Special Issue of Molecules is to report on the recent research work on a number of aspects of PET radiopharmaceuticals and their preclinical and clinical use. More specifically, the content of this Special Issue includes but is not limited to radiolabeling design, radiosynthesis, synthesis techniques, quality control methodologies, GMP production methods, product formulation, in vitro and in vivo preclinical PET evaluations, clinical evaluations, dosimetry, stability study and metabolite analysis, and modeling. 606 $aMedicine$2bicssc 610 $a(S)-(?)-[18F]fluspidine 610 $a[11C]carfentanil 610 $a[18F]AlF 610 $a[18F]FACH 610 $a18F-fluorodeoxyglucose 610 $a18F-labeled analog of FACH 610 $aaffibody molecule 610 $aAlF-radiolabelling 610 $aanimal model 610 $abioconjugation 610 $abioorthogonal chemistry 610 $ablood-brain barrier (BBB) 610 $acarfentanil 610 $aclinical outcomes 610 $aEGFR 610 $aFACH 610 $afentanyl 610 $afluorine-18 610 $agallium-68 610 $aimage-based internal dosimetry 610 $aimaging-based biomarker 610 $aindium-11 610 $ainfection 610 $ainflammation 610 $ainverse electron-demand Diels-Alder ligation 610 $aisotopic exchange 610 $akinetic analysis 610 $alinker 610 $aMCT1/MCT4 lactate transporter inhibitor 610 $ametabolic stability 610 $amolecular imaging 610 $amonocarboxylate transporters (MCTs) 610 $amultiple myeloma 610 $analoxone 610 $ananobody 610 $aNODAGA 610 $aNOTA 610 $aOLINDA 610 $aopioid 610 $aorthotopic xenograft of glioblastoma in mouse 610 $aosteomyelitis 610 $aoverdose 610 $apeptides 610 $aPET 610 $aPET imaging 610 $aPET radiotracers 610 $apharmacokinetics 610 $aPODS 610 $apositron emission tomography 610 $apositron emission tomography (PET) imaging 610 $apositron emission tomography (PET), defluorination 610 $apositron emission tomography/computed tomography 610 $apreclinical development 610 $apreclinical radiopharmaceutical dosimetry 610 $aproteolysis 610 $aradiation safety 610 $aradiochemistry 610 $aradiopharmaceuticals 610 $areceptor occupancy 610 $aSiglec-9 610 $asigma-1 receptor availability 610 $asilicon-based fluoride acceptor 610 $asingle-domain antibody 610 $asmall animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) 610 $aSPECT 610 $aStaphylococcus aureus 610 $asub-millimetre resolution 610 $aSV2A protein 610 $asynaptic loss 610 $atetrazine 610 $atetrazine ligation 610 $athiol-reactive 610 $atumor imaging 610 $aVAP-1 610 $avascular adhesion protein 610 $avulnerable plaque 610 $a?-CCA 615 7$aMedicine 700 $aRoivainen$b Anne$4edt$01323768 702 $aLi$b Xiang-Guo$4edt 702 $aRoivainen$b Anne$4oth 702 $aLi$b Xiang-Guo$4oth 906 $aBOOK 912 $a9910557437003321 996 $aRadiopharmaceuticals for PET Imaging - Issue A$93035833 997 $aUNINA LEADER 01365nas 2200421-- 450 001 9910895751103321 005 20230330203346.0 035 $a(CKB)110978977744283 035 $a(CONSER)---78644072- 035 $a(DE-599)ZDB2708540-5 035 $a(EXLCZ)99110978977744283 100 $a20760727a19uu9999 --- b 101 0 $afre 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRapport annuel de la Banque de la République du Burundi 210 $a[Bujumbura?]$c[Banque de la République du Burundi] 215 $a1 online resource 311 08$aPrint version: Rapport annuel de la Banque de la République du Burundi. 1013-5359 (DLC) 78644072 (OCoLC)2337574 517 1 $aRapport annuel 606 $aEconomic history$2fast$3(OCoLC)fst00901974 606 $aZentralbank$2stw 606 $aWirtschaftslage$2stw 606 $aBurundi$2stw 607 $aBurundi$xEconomic conditions$vPeriodicals 607 $aBurundi$2fast 608 $aPeriodicals.$2fast 615 7$aEconomic history. 615 7$aZentralbank. 615 7$aWirtschaftslage. 615 7$aBurundi. 676 $a332.1/1/0967572 906 $aJOURNAL 912 $a9910895751103321 920 $aexl_impl conversion 996 $aRapport annuel de la Banque de la République du Burundi$94446186 997 $aUNINA